Although no association was found between age of death and SHANK3 levels, an earlier AD diagnosis was significantly associated with lower brain SHANK3a concentrations, suggesting that the loss of SHANK3 may characterize a more aggressive form of the disease. The gene discussed is SHANK3; the disease is Alzheimer disease.